Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02215850
- Locations
- π¨π¦
Alberta Health Services - Cross Cancer Institute, Edmonton, Alberta, Canada
π¨π¦British Columbia Cancer Agency, Vancouver, British Columbia, Canada
π¨π¦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT01098721
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2011-06-13
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 148
- Registration Number
- NCT01098734
- Locations
- π¨π¦
Guilford Dermatology Associates, Surrey, British Columbia, Canada
π¨π¦Department of Dermatology and Skin Sciences, UBC, Vancouver, British Columbia, Canada
π¨π¦Innovaderm Research Inc., Montreal, Quebec, Canada
Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2009-02-05
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00837551
- Locations
- π¨π¦
Innovaderm Research Inc.,, Montreal, Quebec, Canada
Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis
Completed
- Conditions
- Psoriasis
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2009-01-28
- Lead Sponsor
- Welichem Biotech Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00830817
- Locations
- π¨π¦
Innovaderm Research inc., Montreal, Quebec, Canada
Β© Copyright 2025. All Rights Reserved by MedPath